Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.4250
+0.0150 (3.66%)
Nov 11, 2026, 4:10 PM AEDT
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 203.89 million as of November 10, 2026. It is the 22,674th most valuable company in the world and the 461st biggest in Australia. Its market cap has increased by 43.39% in one year.
Market Cap
203.89M
Enterprise Value
193.58M
Revenue
12.67M
Global Rank
Country Rank
#461 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 203.89M, an increase of 307.78%. That is a compound annual growth rate of 5.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 203.89M | 35.42% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 380.73M |
| Tetratherix | 336.92M |
| Racura Oncology | 333.32M |
| BLS Pharmaceuticals | 215.33M |
| Actinogen Medical | 180.85M |
| Orthocell | 157.99M |
| Paradigm Biopharmaceuticals | 153.48M |
| Dimerix | 129.09M |